Inventiva (IVA) Long-Term Investments (2018 - 2025)
Inventiva's (IVA) quarterly Long-Term Investments came in at $275.3 million in Q4 2025, up 157.31% year-on-year from $107.0 million in Q4 2024, and down 70.87% quarter-over-quarter from $945.2 million in Q2 2025.
Inventiva (IVA) Long-Term Investments (2018 - 2025) Analysis & Trends
Inventiva's Long-Term Investments history runs 8 years deep, the most recent figure standing at $275.3 million for Q4 2025.
- On a quarterly basis, Long-Term Investments rose 157.31% year-over-year to $275.3 million in Q4 2025; TTM through Dec 2025 was $275.3 million, a 157.31% increase from a year earlier, with the FY2025 full-year figure at $275.3 million, up 157.31% from the prior year.
- Long-Term Investments retreated to $275.3 million in Q4 2025 per IVA's latest filing, from $945.2 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $945.2 million in Q2 2025 and bottomed at $1.5 million in Q4 2023.
- The 5-year median for Long-Term Investments is $99.4 million (2022), against an average of $195.6 million.
- Across the five-year window, Long-Term Investments slumped 98.33% in 2023 and jumped 6878.0% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $117.8 million in 2021, then slipped by 22.04% to $91.8 million in 2022, then slumped by 98.33% to $1.5 million in 2023, then soared by 6878.0% to $107.0 million in 2024, then soared by 157.31% to $275.3 million in 2025.
- Per Business Quant, the three latest IVA Long-Term Investments figures stand at $275.3 million (Q4 2025), $945.2 million (Q2 2025), and $107.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 275.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 275.29 Mn |
| Jun 30, 2025 | 945.19 Mn |
| Dec 31, 2024 | 106.99 Mn |
| Jun 30, 2024 | 22.75 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Oct 11, 2023 | 3.69 Mn |
| Dec 31, 2022 | 91.84 Mn |
| Dec 31, 2021 | 117.80 Mn |
| Dec 31, 2020 | 143.57 Mn |
| Dec 31, 2019 | 43.77 Mn |
| Dec 31, 2018 | 68.04 Mn |